Glanzmann's thrombasthenia: the spectrum of clinical disease
نویسندگان
چکیده
منابع مشابه
Glanzmann's thrombasthenia: the spectrum of clinical disease.
LANZMANN’S THROMBASTHENIA is a wellG defined inherited disorder of platelet function.’.” It is caused by a deficiency or abnormality of the membrane glycoprotein (GP) IIb-IIIa complex with bleeding due to defective platelet hemostatic plug formation. Thrombasthenia has achieved much recognition for such a rare disease because it has been important in defining G P IIb-IIIa as a platelet receptor...
متن کاملDiagnostic tool for Glanzmann's thrombasthenia clinicopathologic spectrum.
OBJECTIVE To platelet aggregometry and describe the clinical spectrum of Glanzmann's thrombasthenia diagnosed by platelet aggregometry. STUDY DESIGN A case-series. PLACE AND DURATION OF STUDY This study was carried out at the clinical laboratories at the Aga Khan University Hospital, Karachi from January 2003 to January 2006. PATIENTS AND METHODS All patients irrespective of age and gende...
متن کاملClinical spectrum of Parkinson's disease.
I read with interest the recently published article by Professors Khealani and Baig in your prestigious journal. (1) I have some comments because of the importance of the subject. Firstly, if we would like to know how long it takes for patients with Parkinson's disease to develop complications, we must evaluate the interval between two events: the diagnosis of the disease and emergence of compl...
متن کاملThe clinical spectrum of postpartum thyroid disease.
The clinical and biochemical features of postpartum thyroid disease were analysed in 152 antithyroid peroxidase antibody-positive (anti-TPO+ve) women and compared with 239 anti-TPO-ve age-matched control postpartum women. All were assessed monthly for up to 12 months postpartum. Seventy three anti-TPO+ve women developed postpartum thyroiditis (PPT): 19.2% hyperthyroid alone, 49.3% hypothyroid a...
متن کاملThe Clinical Spectrum of Alzheimer ’ s Disease – The Charge Toward
The prevalence of dementia is expected to increase exponentially worldwide. Global estimates of Alzheimer’s disease (AD) generally considered to be the most common subtype of dementia are expected to increase from the current estimated 25 million to 63 million in 2030, and by 2050, a staggering 114 million (Wimo et al., 2003). Traditional approaches in AD diagnosis (Diagnostic and Statistical M...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 1990
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood.v75.7.1383.1383